SecBot SecBot
144 ·Filed Nov 12, 2026

SEPN

Septerna, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed4d 14h ago SEC0001950047-26-010978
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for additional insider selling patterns; a single director sale of this size is not unusual but could signal reduced conviction. The filing does not indicate a lock-up expiry or earnings catalyst timing.

DirectionNeutral
Confidencemedium
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$41.86
T+0 close · Nov 12, 2026 · via day close
Latest settled
+1.77%
T+1 · $42.60
Vs SPY
+2.13%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 12 $41.86entry
  2. T+1 · 4d ago +1.77%α +2.13% · $42.60
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 24d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Alan Ezekowitz filed a Form 144 to sell 100,000 shares of Septerna, Inc. with an estimated aggregate value of $5,234,000. The sale was executed on November 11, 2026, and is being reported on November 12 due to the Veterans Day holiday. This represents a notable insider sale by a director, amounting to approximately 0.21% of the company's $2.5B market cap.

Key Facts

  • Insider: Alan Ezekowitz, Director
  • Shares to be sold: 100,000 shares of common stock
  • Estimated aggregate value: $5,234,000
  • Sale executed on November 11, 2026; filing on November 12 due to federal holiday
  • Shares acquired via open market purchases from March 4-7, 2025
  • Market cap: $2.5B; sale represents ~0.21% of market cap

Financial Impact

Director selling $5.2M worth of shares, representing about 0.21% of market cap

dilutioninsider holdings

Risk Factors

  • Insider selling may indicate reduced confidence in near-term prospects
  • Form 144 is an intent to sell; actual sale may not occur

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010978
Document: 0001950047-26-010978-index.html0001950047-26-010978
Document: 0001950047-26-010978.txt0001950047-26-010978

Track record

25 reports on SEPN

Performance horizon

7 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +55.96% at T+60 after the Apr 13, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 16, 2026today 144 Neutral 2/10 Entry price pending
  3. Nov 12, 20264d ago 144 Neutral 3/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $42.60 Now $41.67 −2.18% settles Nov 20
  5. Nov 12, 20264d ago 144 Neutral 3/10 Viewing Entry $41.86 Now $41.67 −0.45% settles Nov 19
  6. Nov 9, 20267d ago Press Release Bearish 5/10 Entry $52.34 Now $41.67 +20.39% settles Nov 17
  7. Nov 4, 202612d ago 8-K Neutral 3/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
  8. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $47.88 to $48.56 Now $41.67 −12.97% ▲ +1.42% +2.33% vs SPY
  9. Sep 10, 20269w ago Press Release Neutral 2/10 Entry $38.51 to $38.69 Now $41.67 +8.21% ▲ +0.47% +0.69% vs SPY
  10. Sep 3, 202610w ago 3 Neutral 2/10 Entry $36.75 to $39.55 Now $41.67 +13.39% ▲ +7.62% +8.83% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (10h 44m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026